Skip to content
Home/Companies/Biotech/Esperas

Esperas

Biotech·Canada·Active·11yr hold
Entry
2015
Hold
11yr
Status
Active

Who owns Esperas?

Esperas is currently owned by TVM Capital Life Science through TVM Life Science Ventures (2004 vintage), since 2015.

Hand-verified · updated 2026-08-11

TVM Capital Life Science
Investor
TVM Capital Life Science
TVM Life Science Ventures · 2004 · VC

Key facts

HQCanada
SectorBiotech
StatusActive

More from TVM Life Science Ventures

Other portfolio companies in the same fund.

CSA Medical, Inc.
Active
MedTechUnited States· 2024
Jacobian GmbH
Jacobian GmbH
Active
HealthTechGermany· 2024
Myosotis GmbH
Active
HealthTechGermany· 2024
Vektor Medical, Inc.
Active
MedTechUnited States· 2024
Zevra Therapeutics
Zevra Therapeutics
Active
PharmaUnited States· 2023
Egg Medical
Egg Medical
Active
MedTechUnited States· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Esperas

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Esperas.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue